Monopar to Present at the 36th Annual Piper Sandler Healthcare Conference
Monopar Therapeutics (Nasdaq: MNPR) has announced its participation in the 36th Annual Piper Sandler Healthcare Conference. CEO Chandler Robinson will engage in a fireside chat and one-on-one meetings at the event. The presentation is scheduled for December 5, 2024, from 10:30-10:55 am Eastern Time at the Lotte New York Palace in New York. Monopar is a clinical-stage biotechnology company that develops innovative treatments for patients with unmet medical needs.
Monopar Therapeutics (Nasdaq: MNPR) ha annunciato la sua partecipazione al 36° Annuale Piper Sandler Healthcare Conference. Il CEO Chandler Robinson parteciperà a un incontro informale e a incontri individuali durante l'evento. La presentazione è programmata per il 5 dicembre 2024, dalle 10:30 alle 10:55 ora orientale, presso il Lotte New York Palace a New York. Monopar è una azienda biotecnologica in fase clinica che sviluppa trattamenti innovativi per pazienti con bisogni medici non soddisfatti.
Monopar Therapeutics (Nasdaq: MNPR) ha anunciado su participación en la 36ª Conferencia Anual de Atención Médica Piper Sandler. El CEO Chandler Robinson participará en una charla alrededor de la hoguera y en reuniones uno a uno durante el evento. La presentación está programada para el 5 de diciembre de 2024, de 10:30 a 10:55 am, hora del Este, en el Lotte New York Palace en Nueva York. Monopar es una empresa de biotecnología en etapa clínica que desarrolla tratamientos innovadores para pacientes con necesidades médicas insatisfechas.
모노파 제약 (Nasdaq: MNPR)는 제36회 파이퍼 샌들러 헬스케어 컨퍼런스에 참여한다고 발표했습니다. CEO 챈들러 로빈슨이 이벤트에서 화상 대화와 일대일 미팅을 진행할 예정입니다. 발표는 2024년 12월 5일 동부 표준시로 오전 10:30부터 10:55까지 뉴욕의 롯데 뉴욕 팰리스에서 예정되어 있습니다. 모노파는 unmet medical needs를 가진 환자들을 위한 혁신적인 치료법을 개발하는 임상 단계의 생명공학 회사입니다.
Monopar Therapeutics (Nasdaq: MNPR) a annoncé sa participation à la 36e conférence annuelle Piper Sandler sur la santé. Le PDG Chandler Robinson participera à une discussion informelle ainsi qu'à des réunions individuelles durant l'événement. La présentation est prévue pour le 5 décembre 2024, de 10h30 à 10h55, heure de l'Est, au Lotte New York Palace à New York. Monopar est une entreprise de biotechnologie en phase clinique qui développe des traitements innovants pour les patients ayant des besoins médicaux non satisfaits.
Monopar Therapeutics (Nasdaq: MNPR) hat seine Teilnahme an der 36. jährlichen Piper Sandler Healthcare Conference bekannt gegeben. CEO Chandler Robinson wird an einem Gespräch am Kamin sowie an Einzelgesprächen während der Veranstaltung teilnehmen. Die Präsentation ist für den 5. Dezember 2024, von 10:30 bis 10:55 Uhr Eastern Time im Lotte New York Palace in New York, geplant. Monopar ist ein biotechnologisches Unternehmen in klinischer Phase, das innovative Behandlungen für Patienten mit unbefriedigten medizinischen Bedürfnissen entwickelt.
- None.
- None.
WILMETTE, Ill., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biotechnology company focused on developing innovative treatments for patients with unmet medical needs, today announced that Chandler Robinson, MD, Monopar’s Chief Executive Officer, will participate in a fireside chat along with one-on-one meetings at the 36th Annual Piper Sandler Healthcare Conference.
Presentation Details:
Date: December 5, 2024
Time: 10:30-10:55 am Eastern Time
Location: Lotte New York Palace, NY, NY
About Monopar Therapeutics Inc.
Monopar Therapeutics is a clinical-stage biotechnology company with late-stage ALXN-1840 for Wilson disease, and radiopharma programs including Phase 1-stage MNPR-101-Zr for imaging advanced cancers, and Phase 1a-stage MNPR-101-Lu and late preclinical-stage MNPR-101-Ac225 for the treatment of advanced cancers. For more information, visit: www.monopartx.com.
CONTACT:
Monopar Therapeutics Inc.
Investor Relations
Karthik Radhakrishnan
Chief Financial Officer
karthik@monopartx.com
Follow Monopar on social media for updates:
Twitter: @MonoparTx LinkedIn: Monopar Therapeutics
FAQ
When is Monopar Therapeutics (MNPR) presenting at the Piper Sandler Healthcare Conference 2024?
What type of presentation will MNPR give at the Piper Sandler Healthcare Conference?
Where is the 36th Annual Piper Sandler Healthcare Conference being held for MNPR's presentation?
What is the main focus of Monopar Therapeutics (MNPR) as mentioned in the announcement?
